AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SURE VENTURES PLC

Share Issue/Capital Change Mar 13, 2020

4993_rns_2020-03-13_7c02e92c-2f86-44cc-b4c8-bfc1ede99d0d.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1323G

Sure Ventures PLC

13 March 2020

SURE VENTURES PLC

PLACING 

Sure Ventures plc ("the Company") is pleased to announce that it has raised gross proceeds of £ 250,000 by way of a private placing with one Institutional Investor.  The Ordinary Shares have been issued at 100p each, which after the costs and expenses of the issue represents a premium to the last published NAV per share of 95.74p per share.

Application has been made in respect of 250,000 Ordinary Shares to be admitted to trading on the Specialist Funds Segment of the Main Market of London Stock Exchange plc ("Admission").  Admission will become effective and dealings in the Ordinary Shares will commence at 8:00 a.m. (London time) on17th of March 2020.

Following Admission, the Company will have 5,119,956 Ordinary Shares in issue. The total number of voting rights of the Company will be 5,119,956. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.  

For further information, please contact:

Issuer Sure Ventures plc

Gareth Burchell

0207 186 9900
Placing Agent Shard Capital Partners LLP

Damon Heath

0207 186 9900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEFLFLVVDIVLII

Talk to a Data Expert

Have a question? We'll get back to you promptly.